物质信息

ID:1034

名称和标识
商标名
ChalothaneNarcotaneNarkotanHalothaneFluothaneRhodialothanAnestanHalanHalsanNarcotanFluktanPhthorothanumHalotan
别名
BromchlortrifluoraethanumCf3chclbrFreon 123b1BromochlorotrifluoroethaneFluorotaneFtuorotanHalothanFtorotan [Russian]Halothanum [INN-Latin]2-Bromo-2-Chloro-1,1,1-TrifluoroethaneAlotano [Dcit]FluorothaneHalotano [INN-Spanish]Narcotann Ne-Spofa [Russian]Halothane
IUPAC标准名
2-bromo-2-chloro-1,1,1-trifluoroethane
IUPAC传统名
halothane
数据登录号
PubChem SID
CAS号
PubChem CID
化合物性质
理化性质
溶解度
3.45 mg/ml
疏水性(logP)
2.7
描述信息
Drug Groups
approved
Description
A nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. Analgesia may not be adequate. nitrous oxide is often given concomitantly. Because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required. (From AMA Drug Evaluations Annual, 1994, p178)
Indication
For the induction and maintenance of general anesthesia
Pharmacology
Halothane is a general inhalation anesthetic used for induction and maintenance of general anesthesia. It reduces the blood pressure and frequently decreases the pulse rate and depresses respiration. It induces muscle relaxation and reduces pains sensitivity by altering tissue excitability. It does so by decreasing the extent of gap junction mediated cell-cell coupling and altering the activity of the channels that underlie the action potential.
Toxicity
Toxic effects of halothane include malignant hyperthermia and hepatitis.
Affected Organisms
Humans and other mammals
Biotransformation
Halothane is metabolized in the liver, primarily by CYP2E1, and to a lesser extent by CYP3A4 and CYP2A6.
References
• Bovill JG: Inhalation anaesthesia: from diethyl ether to xenon. Handb Exp Pharmacol. 2008;(182):121-42. [Pubmed]
External Links
分子图谱
暂无数据
点击上传数据
参考文献
• Bovill JG: Inhalation anaesthesia: from diethyl ether to xenon. Handb Exp Pharmacol. 2008;(182):121-42. Pubmed